US In Vitro Diagnostics (IVD) Market by Application (Cancer, Infectious Diseases, Diabetes, Cardiology), Technology (Molecular Diagnostics, Immunoassay, Clinical Chemistry, Microbiology), End User (Hospitals & Laboratories) & by Region – 2020 to 2025

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: April 9, 2020
Clear
SKU: GMS-3199 Category:

The US In Vitro Diagnostics (IVD) Market is calculated to reach USD 92.11 billion by 2025, growing at a CAGR of 5.76% during the forecast period 2020-2025. The rising demand for early and accurate disease diagnosis, increasing adoption of fully-automated instruments and automation in laboratories, increasing adoption of point-of-care testing, and growing awareness of personalized medicine are the key factors driving the growth of the market.

US In Vitro Diagnostics (IVD) Market by Application (Cancer, Infectious Diseases, Diabetes, Cardiology), Technology (Molecular Diagnostics, Immunoassay, Clinical Chemistry, Microbiology), End User (Hospitals & Laboratories) & by Region - 2020 to 2025 1

US In Vitro Diagnostics (IVD) Market by Application (Cancer, Infectious Diseases, Diabetes, Cardiology), Technology (Molecular Diagnostics, Immunoassay, Clinical Chemistry, Microbiology), End User (Hospitals & Laboratories) & by Region - 2020 to 2025 2

US In Vitro Diagnostics (IVD) Market by Application (Cancer, Infectious Diseases, Diabetes, Cardiology), Technology (Molecular Diagnostics, Immunoassay, Clinical Chemistry, Microbiology), End User (Hospitals & Laboratories) & by Region - 2020 to 2025 3

US In Vitro Diagnostics (IVD) Market by Application (Cancer, Infectious Diseases, Diabetes, Cardiology), Technology (Molecular Diagnostics, Immunoassay, Clinical Chemistry, Microbiology), End User (Hospitals & Laboratories) & by Region - 2020 to 2025 4

US In Vitro Diagnostics (IVD) Market by Application (Cancer, Infectious Diseases, Diabetes, Cardiology), Technology (Molecular Diagnostics, Immunoassay, Clinical Chemistry, Microbiology), End User (Hospitals & Laboratories) & by Region - 2020 to 2025 5

US In Vitro Diagnostics (IVD) Market by Application (Cancer, Infectious Diseases, Diabetes, Cardiology), Technology (Molecular Diagnostics, Immunoassay, Clinical Chemistry, Microbiology), End User (Hospitals & Laboratories) & by Region - 2020 to 2025 6

US In Vitro Diagnostics (IVD) Market by Application (Cancer, Infectious Diseases, Diabetes, Cardiology), Technology (Molecular Diagnostics, Immunoassay, Clinical Chemistry, Microbiology), End User (Hospitals & Laboratories) & by Region - 2020 to 2025 7

US In Vitro Diagnostics (IVD) Market by Application (Cancer, Infectious Diseases, Diabetes, Cardiology), Technology (Molecular Diagnostics, Immunoassay, Clinical Chemistry, Microbiology), End User (Hospitals & Laboratories) & by Region - 2020 to 2025 8

1 U.S. In Vitro Diagnostics (IVD) Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 U.S. In Vitro Diagnostics (IVD) Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 U.S. In Vitro Diagnostics (IVD) Market – Industry Market Entry Scenario
4.1 Regulatory Framework Overview
4.2 New Business and Ease of Doing business index
4.3 Case studies of successful ventures
4.4 Customer Analysis – Top 10 companies

5 U.S. In Vitro Diagnostics (IVD) Market – Market Forces
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.2 Opportunities
5.2.3 Challenges
5.3 Porters Analysis of Market
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining powers of customers
5.3.3 Threat of new entrants
5.3.4 Rivalry among existing players
5.3.5 Threat of substitutes

6 U.S. In Vitro Diagnostics (IVD) Market – Strategic Analysis
6.1 Value Chain analysis
6.2 Supplier and distributor analysis (Market share and product dealing strategies)

7 U.S. In Vitro Diagnostics (IVD) Market – By Product (Market Size – & million/billion)
7.1 Reagents & Kits
7.2 Instruments
7.3 Services

8 U.S. In Vitro Diagnostics (IVD) Market – By Technology
8.1 Immunoassay
8.2 Hematology
8.3 Clinical Chemistry
8.4 Molecular Diagnostics
8.5 Coagulation
8.6 Microbiology
8.7 Others

9 U.S. In Vitro Diagnostics (IVD) Market – By Application
9.1 Infectious Diseases
9.2 Diabetes
9.3 Autoimmune Diseases
9.4 Nephrology
9.5 Oncology
9.6 Cardiology
9.7 Drug Testing/Pharmacogenomics
9.8 HIV/Aids
9.9 Other

10 U.S. In Vitro Diagnostics (IVD) Market – By End-User
10.1 Hospitals
10.2 Laboratories
10.3 Point-Of-Care Testing
10.4 Patient Self-Testing
10.5 Academic Institutes

11 U.S. In Vitro Diagnostics (IVD) Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships

12 U.S. In Vitro Diagnostics (IVD) Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Thermo Fisher Scientific
12.3 Siemens AG
12.4 Sysmex Corporation
12.5 Danaher Corporation
12.6 Johnson & Johnson
12.7 Agilent Technologies
12.8 Roche Diagnostics
12.9 Becton, Dickinson and Company
12.10 Bio-Rad Laboratories, Inc.
12.11 Qiagen
12.12 Company 11 & more

13 U.S. In Vitro Diagnostics (IVD) Market – Appendix
13.1 Sources
13.2 Abbreviations